KE2900A - N-(1-benzylpiperid-4-yl)-benzamides, methods for their preparation and pharmaceutical compositions containing them - Google Patents
N-(1-benzylpiperid-4-yl)-benzamides, methods for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- KE2900A KE2900A KE2900A KE290078A KE2900A KE 2900 A KE2900 A KE 2900A KE 2900 A KE2900 A KE 2900A KE 290078 A KE290078 A KE 290078A KE 2900 A KE2900 A KE 2900A
- Authority
- KE
- Kenya
- Prior art keywords
- benzylpiperid
- benzamides
- preparation
- methods
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
- C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Otolaryngology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB12572/74A GB1507462A (en) | 1974-03-21 | 1974-03-21 | N-heterocyclic substituted benzamides methods for their preparation and compositions containing them |
| GB3540274 | 1974-08-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KE2900A true KE2900A (en) | 1978-12-01 |
Family
ID=26249107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KE2900A KE2900A (en) | 1974-03-21 | 1978-11-14 | N-(1-benzylpiperid-4-yl)-benzamides, methods for their preparation and pharmaceutical compositions containing them |
Country Status (11)
| Country | Link |
|---|---|
| JP (1) | JPS584019B2 (en) |
| AR (1) | AR216043A1 (en) |
| CH (1) | CH602641A5 (en) |
| DK (1) | DK147854C (en) |
| ES (5) | ES435753A1 (en) |
| FI (1) | FI60200C (en) |
| FR (1) | FR2264530A1 (en) |
| KE (1) | KE2900A (en) |
| NL (1) | NL159660B (en) |
| NO (1) | NO144108C (en) |
| SE (1) | SE427750B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1513631A (en) * | 1976-02-17 | 1978-06-07 | Gallardo Antonio Sa | Piperidine derivatives |
| GB1561023A (en) * | 1977-04-22 | 1980-02-13 | Beecham Group Ltd | 2-methoxy - 5 - chloro aniline derivatives |
| FR2446274A1 (en) * | 1979-01-15 | 1980-08-08 | Delalande Sa | 5-Acetoxy:methyl and 5-chloro:methyl 2-methoxy benzamide(s) - and related cpds. have neuroleptic activity and are used for psychic disorders |
| EP0343307A1 (en) * | 1988-05-26 | 1989-11-29 | Fabrica Espanola De Productos Quimicos Y Farmaceuticos, S.A. | 4-Piperidinealkanamine derivatives |
| FR2674849B1 (en) * | 1991-04-02 | 1994-12-23 | Logeais Labor Jacques | NOVEL N-CYCLOHEXYL BENZAMIDES OR THIOBENZAMIDES DERIVATIVES, THEIR PREPARATIONS AND THEIR THERAPEUTIC APPLICATIONS. |
| FR2766486B1 (en) * | 1997-07-25 | 1999-09-17 | Logeais Labor Jacques | HIGH AND LOW GASTROINTESTINAL MOTOR STIMULATING BENZAMIDE CYCLOALKYLES |
| FR2766484B1 (en) * | 1997-07-25 | 1999-09-17 | Logeais Labor Jacques | NOVEL STIMULATING BENZAMIDE DERIVATIVES OF HIGH AND LOW GASTROINTESTINAL MOTORITY |
| PT1893603E (en) * | 2005-06-02 | 2009-11-24 | Hoffmann La Roche | Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists |
| KR100976063B1 (en) * | 2007-03-16 | 2010-08-17 | 동아제약주식회사 | Novel benzamide derivatives and process for the preparation thereof |
| HUE039164T2 (en) * | 2011-11-29 | 2018-12-28 | Vivozon Inc | Novel benzamide derivative and use thereof |
-
1975
- 1975-03-17 AR AR257994A patent/AR216043A1/en active
- 1975-03-18 ES ES435753A patent/ES435753A1/en not_active Expired
- 1975-03-18 ES ES435757A patent/ES435757A1/en not_active Expired
- 1975-03-18 ES ES435754A patent/ES435754A1/en not_active Expired
- 1975-03-18 ES ES435755A patent/ES435755A1/en not_active Expired
- 1975-03-18 ES ES435756A patent/ES435756A1/en not_active Expired
- 1975-03-20 DK DK117675A patent/DK147854C/en not_active IP Right Cessation
- 1975-03-20 FR FR7509371A patent/FR2264530A1/en active Granted
- 1975-03-20 FI FI750825A patent/FI60200C/en not_active IP Right Cessation
- 1975-03-20 SE SE7503196A patent/SE427750B/en not_active IP Right Cessation
- 1975-03-20 CH CH355075A patent/CH602641A5/xx not_active IP Right Cessation
- 1975-03-20 NO NO750957A patent/NO144108C/en unknown
- 1975-03-21 NL NL7503417.A patent/NL159660B/en not_active IP Right Cessation
- 1975-03-22 JP JP7534871A patent/JPS584019B2/en not_active Expired
-
1978
- 1978-11-14 KE KE2900A patent/KE2900A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS50129573A (en) | 1975-10-13 |
| FR2264530A1 (en) | 1975-10-17 |
| FI750825A (en) | 1975-09-22 |
| NL7503417A (en) | 1975-09-23 |
| ES435754A1 (en) | 1977-04-01 |
| DK117675A (en) | 1975-09-22 |
| DK147854C (en) | 1985-07-22 |
| JPS584019B2 (en) | 1983-01-24 |
| AR216043A1 (en) | 1979-11-30 |
| FI60200C (en) | 1981-12-10 |
| CH602641A5 (en) | 1978-07-31 |
| NL159660B (en) | 1979-03-15 |
| SE427750B (en) | 1983-05-02 |
| FR2264530B1 (en) | 1978-11-10 |
| SE7503196L (en) | 1975-09-22 |
| NO144108B (en) | 1981-03-16 |
| ES435757A1 (en) | 1977-04-01 |
| ES435756A1 (en) | 1977-04-01 |
| ES435755A1 (en) | 1977-04-01 |
| ES435753A1 (en) | 1977-04-01 |
| NO144108C (en) | 1981-06-24 |
| NO750957L (en) | 1975-09-23 |
| FI60200B (en) | 1981-08-31 |
| DK147854B (en) | 1984-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL49204A0 (en) | N-(4-piperidinyl)-n-phenylamides and-carbamates,their preparation and pharmaceutical compositions containing them | |
| IL46967A (en) | N-pyrrolidyl-, n-piperidyl-,n-pyridyl-and n-pyrroly-polyfluoroalkyl-benzamide derivatives, their preparation and pharmaceutical compositions comprising them | |
| IL47625A (en) | 4-heterocyclyl-6,7-dialkoxyquin-azoline derivatives and pharmaceutical compositions containing them | |
| IL46695A (en) | Substituted n-(1-benzylpyrrolidinyl-2-alkyl)-benzamides, their preparation and pharmaceutical compositions containing them | |
| IL48593A (en) | 1-substituted-4-benzylidenepiperidine derivatives, their preparation and pharmaceutical compositions comprising them | |
| IL47529A0 (en) | New benzimidazolinone derivatives,their preparation and pharmaceutical compositions containing them | |
| IL46959A0 (en) | 1,1-diaryl-1-oxadiazolyl-alkylamines,their preparation and pharmaceutical compositions containing them | |
| IL47360A0 (en) | Cephalosporins,their preparation and pharmaceutical compositions containing them | |
| IL48061A (en) | 4a-phenyl-cis-decahydroisoquinoline derivatives, their preparation and pharmaceutical compositions containing them | |
| IL47329A0 (en) | New pyridobenzodiazepinones,their preparation and pharmaceutical compositions containing them | |
| KE2900A (en) | N-(1-benzylpiperid-4-yl)-benzamides, methods for their preparation and pharmaceutical compositions containing them | |
| NZ178313A (en) | Certain amines, and pharmaceutical compositions containingthem | |
| IL46631A0 (en) | New cephalosporins,their preparation and pharmaceutical compositions containing them | |
| IL48678A0 (en) | N-(2-pyrrolidinylmethyl)-2-methoxybenzamide derivatives,their preparation and pharmaceutical compositions containing them | |
| IL47149A0 (en) | New amino acid derivatives,their preparation and pharmaceutical compositions containing them | |
| IL47590A0 (en) | Vincaminic acid amides,their preparation and pharmaceutical compositions containing them | |
| IL47196A (en) | 7-substituted-8-aminomethyl-isoflavone derivatives, their preparation and pharmaceutical compositions containing them | |
| IL48756A (en) | Substituted indoles, their preparation and pharmaceutical compositions containing them | |
| IL47503A0 (en) | Novel heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| HK20881A (en) | Cinnamamides,their preparation and pharmaceutical compositions containing them | |
| IL47195A0 (en) | New 5-substituted phenyltetrazoles,their preparation and pharmaceutical compositions containing them | |
| IL47270A0 (en) | New peptides,their preparation and pharmaceutical compositions containing them | |
| IL49438A0 (en) | Phenyl bicyclooctanealkyl amines,their preparation and pharmaceutical compositions containing them | |
| IL46696A (en) | Substituted n-(2-pyrrolidinylalkyl)benzamides, their preparation and pharmaceutical compositions containing them | |
| IL48526A0 (en) | Diaryloxy-imidazolyl-o,n-acetals,their preparation and pharmaceutical compositions containing them |